CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Acceleron Pharma Inc Company Snapshot
Acceleron Pharma Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Acceleron Pharma Inc with three other companies in this sector in the United States: Adma Biologics Inc (2018 sales of $16.99 million of which 59% was Plasma Collection Center), La Jolla Pharmaceutical Company ($10.06 million of which 100% was Pharmaceutical Products), and Curis, Inc. ($10.43 million of which 100% was Therapeutic Drug Dev).

Sales Analysis. Acceleron Pharma Inc reported sales of $13.99 million for the year ending December of 2018. This represents an increase of 3.8% versus 2017, when the company's sales were $13.48 million. Despite this increase, sales are still well below the level achieved in 2016, when Acceleron Pharma Inc reported sales of $27.77 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Acceleron Pharma Inc
  Stock Performance Chart for Acceleron Pharma Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (9/6/2019): 44.54
(Figures in U.S. Dollars)
1 Week -0.8%   13 Weeks 0.2%  
4 Weeks 12.2%   52 Weeks -12.8%  
 
Acceleron Pharma Inc Key Data:
  Ticker: XLRN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 13,991,000
(Year Ending Jan 2019).
Employees: 173
  Currency: U.S. Dollars Market Cap: 2,349,612,117
  Fiscal Yr Ends: December Shares Outstanding: 52,752,854
  Share Type: Common Closely Held Shares: 7,644,719
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.